Analysis of the risk of oncological adverse events associated with infliximab in combination with azathioprine compared to monotherapy: insights from the FAERS database. [PDF]
Qiao Q+9 more
europepmc +1 more source
SELECTIVE SUPPRESSION OF MURINE ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY BY AZATHIOPRINE
Elizabeth C. Purves, M. C. Berenbaum
openalex +1 more source
Azathioprine versus d‐penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold [PDF]
Harold E. Paulus+15 more
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source
Compatibility of Post-Kidney Transplant Immunosuppression Therapy with Lactation. [PDF]
Gomez-Casado G+3 more
europepmc +1 more source
Strength of the human mixed lymphocyte reaction (MLR) and its suppression by azathioprine or 6‐mercaptopurine. [PDF]
SA Al‐Safi, JL Maddocks
openalex +1 more source
Abstract Objectives Reports of real‐world data concerning chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are limited in Japan. This study aimed to investigate the diagnostic testing and treatment performed in patients diagnosed with CIDP in Japan. Methods Using a Japanese commercial medical information database, we analyzed diagnostic
Motoi Kuwahara+5 more
wiley +1 more source
Mortality Rates Among Individuals Diagnosed with Pemphigus: 12-Year Experience in Tehran, Iran. [PDF]
Namazi N+4 more
europepmc +1 more source
In Vitro Growth of Rat Blastocyst under the Effect of Azathioprine [PDF]
Amos Fein, Vladimir Toder, L. Nebel
openalex +1 more source